Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel
NASDAQ:ONMD

OneMedNet Q1 2024 Earnings Report

OneMedNet logo
$0.65 -0.04 (-5.48%)
Closing price 09/22/2026 04:00 PM Eastern
Extended Trading
$0.68 +0.03 (+4.31%)
As of 09/22/2026 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

OneMedNet EPS Results

Actual EPS
-$0.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

OneMedNet Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

OneMedNet Announcement Details

Quarter
Q1 2024
Date
12/17/2024
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Powered by Quartr

Earnings Documents

OneMedNet's Q1 2024 Quarterly reportQuarterly report
(10-Q)

OneMedNet Earnings Headlines

Onemednet Corporation and Atropos Health Expand Commercial Reach Through Multi-Year Resale Agreement
September 22 at 2:17 PM  |  marketscreener.comM
Atropos Health Scales Federated Evidence Network with Multimodal Data Partners to Accelerate Health Analytics and AI Model Development
September 22 at 1:40 PM  |  businesswire.comhttps://www.businesswire.com/news/home/20260922102002/en/atropos-health-scales-federated-evidence-network-with-multimodal-data-partners-to-accelerate-health-analytics-and-ai-model-development/
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.tc pixel
 |  Porter & Company (Ad)
OneMedNet Announces Multi-Year Strategic Partnership with Atropos Health to Expand Access to Regulatory-Grade Real-World Data
September 22 at 8:51 AM  |  quiverquant.comQ
OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health
September 22 at 8:40 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/22/3366361/0/en/onemednet-expands-commercial-reach-through-multi-year-resale-agreement-with-atropos-health.html
Comparing OneMedNet (NASDAQ:ONMD) & Veeva Systems (NYSE:VEEV)
September 22 at 5:15 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31039223
See More OneMedNet Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like OneMedNet? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OneMedNet and other key companies, straight to your email.

About OneMedNet

OneMedNet (NASDAQ:ONMD) Corp. is a healthcare technology company focused on making medical imaging data more accessible for research, clinical development and artificial intelligence applications. Its platform is designed to help organizations use real-world imaging data while maintaining data privacy, security and institutional control.

The company’s offerings support the secure exchange and analysis of medical imaging information through a decentralized, federated model. This approach allows participating healthcare providers and data owners to contribute insights and data without necessarily transferring the underlying records to a central repository. OneMedNet serves healthcare organizations, life sciences companies, medical researchers and technology developers.

OneMedNet became a publicly traded company following its business combination with Data Knights Acquisition Corp. The company describes its network as serving participants across multiple international markets, although specific geographic coverage may vary by partnership and regulatory requirements.

View OneMedNet Profile
Earnings Tools